View Post

Underenrollment in clinical trials: Patients not the problem

In Clinical Trials by Barbara Jacoby

By: UT Southwestern Medical Center From: medicalxpress.com The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies. That’s a key finding by researchers in UT Southwestern’s new Department of Population and Data Sciences. The authors of the study published this month in the Journal of …

View Post

Clinical Trial Saves Life of Stage 4 Kidney Cancer Patient

In Clinical Trials by Barbara Jacoby

By: Bianca Castro From: nbcdfw.com When a well-known journalist in Dallas learned he had stage 4 kidney cancer, he was told he had three, possibly four, years to live. One year, later, the tumor threatening his life is gone and it’s thanks to a clinical trial at UT Southwestern. Robert Wilonsky will tell you there’s nothing special about him. He’ll …

View Post

Study: Wearable fitness monitors useful in cancer treatment

In In The News by Barbara Jacoby

From: utsouthwestern.edu Wearable fitness trackers, such as Fitbits, that measure steps taken per day may be a useful tool to evaluate and help treat cancer patients, researchers at UT Southwestern’s Simmons Cancer Center have shown. A pilot study of older cancer patients found that they were willing to wear physical activity monitors (PAMs) for 10 weeks or more and used them correctly. …

View Post

Cancer drug targeting ‘gene fusions’ has 93% response rate in children

In In The News by Barbara Jacoby

A drug targeting a gene fusion that occurs across many types of cancer was effective in 93 percent of pediatric patients, researchers at UT Southwestern’s Simmons Cancer Center announced. The drug is the first cancer drug to receive FDA-breakthrough therapy designation for patients with a specific gene fusion, no matter the site of origin of the cancer. The research appears …